NASDAQ: AUPH

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -46.77% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -44.78% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -45.45% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -42.69% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -41.65% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -38.71% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -38.24% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -36.43% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -35.77% away from its yearly high level, during the last trading session. The

Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH) was trading -32.73% away from its yearly high level, during the last trading session. The